Methyl 3-bromobicyclo[1.1.1]pentane-1-carboxylate, 97%, 100mg

rEGCase II assisted by Activator II1vial

(3,5-Bis((3,5-dimethoxybenzyl)oxy)phenyl)methanol, 95+%, 200mg

cis-tert-Butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride, 97.0%, 1g

Formaldehyde Sodium Bisulfite Hemihydrate>98.0%(T)500g

(4-((3-Hydroxypropyl)carbamoyl)phenyl)boronic acid, 95.0%, 100mg

tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 100mg

ETHYL 9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE, 97.0%, 500mg

Methyl 5-amino-6-chloro-3-pyridinecarboxylate, 95.0%, 5g

METHYL 7-(TRIFLUOROMETHYL)-1H-INDOLE-4-CARBOXYLATE, 97.0%, 100mg

Methyl 2-cyano-3,4-dimethylpent-2-enoate, 97.0%, 25g

phenylboronic acid hydrate, 95.0%, 100g

(3-((4-(2-Methoxyethyl)phenoxy)methyl)phenyl)boronic acid, 95%, 5g